Answers are grounded in this paper and cite their sources.
The U.S. Drug Supply Chain Security Act (DSCSA) requires stakeholders in the pharmaceutical supply chain to provide a means for unit traceability, type verification, and serialization of prescription medications.Considering the number of prescriptions dispensed by high-volume retail pharmacy operations, those very systems also encounter significant challenges with real-time compliance, such as managing inventory and keeping patients safe.This paper introduces an integrated architecture that marries DSCSA-compliant serialization standards with state-of-the-art supply chain visibility tools available from RFXCEL.The system utilizes the capabilities of the end-to-end traceability provided by the Traceability System of rFXCEL (rTS), the Integrated Monitoring (rIM) and the Accurate Immunization Management (rAIM) systems, including handling of temperature-sensitive drugs and integration with the electronic health records (EHRs) and public health records.A pilot implementation was performed in five high-volume retail pharmacies, where RFXCEL was interfaced to Rajesh Karvannan https://iaeme.com/Home/
No takes yet. Share an insight, caveat, or question.
Rajesh Karvannan (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: